Premature menopause is linked to 40% increase in heart disease risk

Premature Menopause Carries a 40% Lifetime Bump in Heart Disease Risk — And the Disparity Falls Hardest on Black Women

Women who enter menopause before age 40 carry a 40% higher lifetime risk of coronary heart disease compared to those who go through the transition at typical age, according to a study published Wednesday in JAMA Cardiology. The finding sharpens a decades-old suspicion into something clinicians can act on — and it arrives alongside an uncomfortable truth about who bears the burden most.

The study pooled six longitudinal cohorts tracking more than 10,000 women without pre-existing coronary heart disease from 1964 through 2018. Among 3,522 Black women in the study, 15.5% experienced premature menopause. Among 6,514 white women, that figure was 4.8%. The gap matters because the cardiovascular risk itself is lifelong, not just near-term.

The study cannot determine whether premature menopause drives cardiovascular risk, or whether it is a signal of whatever underlying biology caused the early transition in the first place. That distinction matters enormously for clinical response. If premature menopause is itself the driver — because the body loses estrogen years earlier than normal — then the implication points toward hormone replacement therapy as a potential countermeasure, a fraught and contested area of preventive medicine. If premature menopause is merely a marker, then the real culprit remains unmeasured, though the risk signal is still useful for flagging patients who deserve aggressive cardiovascular prevention. The study was not designed to adjudicate between these two possibilities, and the authors are upfront about it. There is biological plausibility for the direct mechanism: estrogen withdrawal accelerates atherosclerosis, and the vasculature of a 35-year-old who has been without it for years is plausibly different from that of a 50-year-old who just lost it. But that hypothesis is not proven here.

"When women sustain premature menopause, they are young and have low near-term risk," said Pradeep Natarajan, director of preventive cardiology at Massachusetts General Hospital, who co-authored an earlier UK Biobank study on the same link in 2019 but was not involved in the new paper. "This study indicates that having sustained premature menopause is an important lifelong signal, which could be incorporated into cardiovascular risk optimization earlier in life."

Co-author Priya Freaney, a cardiologist and director of the Women's Heart Care Program at Northwestern University, frames it practically: "In all individuals who have premature menopause, there's a ton of potential for raising awareness. I encourage patients to be more proactive about bringing it up with their physicians as a means to develop a prevention plan."

The racial disparity in premature menopause rates is not explained by the study, and that question deserves its own attention. Why more Black women entered premature menopause is unknown — though rates of early menarche are also higher in this group, and factors linked to that include lower birth weight, higher childhood weight gain, and what researchers call "weathering": the cumulative toll of lifelong racial stressors including discrimination, poverty, housing segregation, pollution, and chronic fear. These are biological channels as well as social ones, but the study was not designed to parse which matter most.

"This disparity reflects many other disparities we see in heart disease risk factors and heart disease itself in Black versus white women," Freaney said. "There's a lot more to be learned about why this is occurring more often in Black women, and then what we can do to mitigate these disparities."

Menopause typically happens around age 51. Before 45 is termed early menopause; before 40 is premature. Other reproductive factors tied to cardiovascular outcomes include preeclampsia and gestational diabetes — conditions that, like premature menopause, create windows for earlier intervention if clinicians choose to use them. The question this study leaves open is whether earlier identification of risk actually changes outcomes when the mechanism driving that risk is still not understood. That is a genuine limitation, not a reason to ignore the signal. The authors' position, and Natarajan's, is that it isn't.

The research was funded in part by the American College of Cardiology/Merck Research Fellowship. Coverage of chronic health conditions at STAT is supported by a grant from Bloomberg Philanthropies.